Company
Management
Martin Olin, EMBA, M.Sc.
Chief Executive Officer
Martin Olin, EMBA, M.Sc., is a Danish national, born in 1969. He served on the Board of Symphogen in… Read more 2001-2008. Martin Olin joined the company in 2012 as Chief Financial Officer and was appointed Chief Executive Officer in 2016.
Before joining Symphogen, Martin Olin was a senior partner with SLS Invest, a Scandinavian based healthcare focused private equity fund and he has held managerial positions in Novo Nordisk, including Finance Director, EMEA.
Before joining Symphogen, Martin Olin was a senior partner with SLS Invest, a Scandinavian based healthcare focused private equity fund and he has held managerial positions in Novo Nordisk, including Finance Director, EMEA.
Mikkel Wandahl Pedersen, Ph.d
SVP and Acting Chief Scientific Officer
Mikkel Wandahl Pedersen, PhD, is a Danish national, born in 1973. He joined Symphogen in 2006 as sci… Read moreentist, was appointed Director of Cancer Biology and Immunology in 2012 and Vice President of Antibody Discovery and Research in 2018.
Before joining Symphogen, Mikkel W. Pedersen was leader of the receptor tyrosine kinase group at Department of Radiation Biology at Copenhagen University Hospital. Mikkel W. Pedersen has authored over 40 peer-reviewed publications
Before joining Symphogen, Mikkel W. Pedersen was leader of the receptor tyrosine kinase group at Department of Radiation Biology at Copenhagen University Hospital. Mikkel W. Pedersen has authored over 40 peer-reviewed publications
Rikke Bolding Jensen, M.Sc, Ph.d,
SVP, CMC
Rikke Bolding Jensen, M.Sc, Ph.d, is a Danish national, born in 1969. She joined Symphogen in 2014.… Read more
Before joining Symphogen, Rikke Bolding Jensen served development and CMC project management positions in Nycomed/Takeda and Maxygen.
Before joining Symphogen, Rikke Bolding Jensen served development and CMC project management positions in Nycomed/Takeda and Maxygen.
Karin Garre, MD
Chief Operating Officer
Karin Garre, MD, is a Danish-national, born in 1957. She joined Symphogen in 2018 as Senior Vice Pre… Read moresident to take the lead for strategic portfolio management.
Before joining Symphogen, Karin Garre has held managerial and executive leadership positions in the Danish health care sector and international pharmaceutical pharma and biotech industries such as Novo Nordisk, Nycomed, Genmab, T-cellic and NeuroSearch.
Before joining Symphogen, Karin Garre has held managerial and executive leadership positions in the Danish health care sector and international pharmaceutical pharma and biotech industries such as Novo Nordisk, Nycomed, Genmab, T-cellic and NeuroSearch.
Lisbet Løschenkohl
SVP, People & Facility
Lisbet Løschenkohl is a Danish national, born in 1967. She joined Symphogen in 2008 as Head of HR.<… Read morebr />
Before joining Symphogen, Lisbet Løschenkohl headed the HR and Facility function in Rheosciene and Center for Clinical and Basic Research.